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Summary
Bariatric surgery is recognized as the most clinically and cost-effective treatment for
people with severe and complex obesity. Many people presenting for surgery have
pre-existing low vitamin and mineral concentrations. The incidence of these may
increase after bariatric surgery as all procedures potentially cause clinically significant
micronutrient deficiencies. Therefore, preparation for surgery and long-term nutri-
tional monitoring and follow-up are essential components of bariatric surgical care.
These guidelines update the 2014 British Obesity and Metabolic Surgery Society
nutritional guidelines. Since the 2014 guidelines, the working group has been
expanded to include healthcare professionals working in specialist and non-specialist
care as well as patient representatives. In addition, in these updated guidelines, the
current evidence has been systematically reviewed for adults and adolescents under-
going the following procedures: adjustable gastric band, sleeve gastrectomy, Roux-
en-Y gastric bypass and biliopancreatic diversion/duodenal switch. Using methods
based on Scottish Intercollegiate Guidelines Network methodology, the levels of evi-
dence and recommendations have been graded. These guidelines are comprehensive,
Abbreviations: 25OHD, 25-hydroxyvitamin D; AGB, adjustable gastric band; BOMSS, British Obesity and Metabolic Surgery Society; BPD/DS, duodenal switch; CT, non-randomized controlled
trials; EL, evidence level; FPG, fasting plasma glucose; GPP, good practice point; OAGB/MGB, one anastomosis gastric bypass/mini gastric bypass; PIVKA-II, protein induced by vitamin K
absence or antagonism; PTH, parathyroid hormone; RCT, randomized controlled trial; ROS, Royal Osteoporosis Society; RYGB, Roux-en-Y gastric bypass; SADIs, single anastomosis duodenal ileal
bypass with sleeve gastrectomy; SG, sleeve gastrectomy; SIGN, Scottish Intercollegiate Guidelines Network.
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encompassing preoperative and postoperative biochemical monitoring, vitamin and
mineral supplementation and correction of nutrition deficiencies before, and follow-
ing bariatric surgery, and make recommendations for safe clinical practice in the
U.K. setting.
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1 | INTRODUCTION
Bariatric surgery is recognized as the most clinically and cost-effective
treatment option for people with severe and complex obesity.1 All
bariatric surgery procedures impact on nutrition to varying degrees
and can potentially cause clinically significant deficiencies of
micronutrients.2–4
The British Obesity and Metabolic Surgery Society (BOMSS)
published its first nutritional guidelines in 2014 following a review
of U.K. clinicians, which showed widespread variation in nutritional
monitoring and vitamin and mineral supplementation both pre- and
post-surgery.5,6 This is an update and review of those guidelines.
Since the 2014 guidelines, a number of other nutritional guidelines
for the care of people who undergo bariatric surgery have been
published.3,4,7–11 However, not all have been specifically related to
micronutrition, had dietetic involvement and included either pri-
mary care or patient representatives. In addition, previous guidance
aimed at the management of adolescents undergoing bariatric sur-
gery has only included general nutritional recommendations,12–14
despite this vulnerable group being at high risk of developing
nutritional deficiencies.15–19 Until recent guidelines by Shawe
et al,11 there has been little detail included in previous guidelines
on recommendations for the nutritional management of pregnancy
post-surgery. In summary, there are no up-to-date, comprehensive
U.K. guidelines for the perioperative and postoperative nutritional
care of patients undergoing bariatric surgery.
In this update of BOMSS nutritional guidelines,5 we have
aimed to systematically review the current evidence for preopera-
tive and postoperative biochemical monitoring and micronutrient
replacement for adolescents and adults undergoing bariatric sur-
gery, including pregnancy, and to update the recommendations for
safe practice in the U.K. setting. We have focussed on the proce-
dures: adjustable gastric band (AGB), sleeve gastrectomy (SG),
Roux-en-Y gastric bypass (RYGB) and duodenal switch (BPD/DS),
as these were the most common procedures being undertaken at
the time of the literature search. The aim of this work was to pro-
duce a set of guidelines that are comprehensive but remain acces-
sible to healthcare professionals involved in preparation and
aftercare of people undergoing bariatric surgery, in particular those
working in the United Kingdom.
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2 | METHODS
Members of the original BOMSS nutritional guidelines were involved
in the update with additional members selected on the basis of their
expertise and experience in supporting people who undergo bariatric
surgery. In addition, two patient representatives were included. The
membership therefore included six dietitians (MO, GP, NW, DT, KC
and JD), two general practitioners (HP and CH), three physicians
(JP, RB and JM), two chemical pathologists (JB and MS), two surgeons
(RWand KM) and two patient representatives (AB and IM). These
guidelines aimed to address four main areas of clinical management
for patients undergoing bariatric surgery.
What are the clinical recommendations that are appropriate for:
• Preoperative nutritional screening/or monitoring before bariatric
surgery;
• Postoperative nutritional screening and/or monitoring after
bariatric surgery;
• Vitamin and mineral supplementation to prevent nutritional
deficiencies following bariatric surgery;
• Treatment of nutritional deficiencies before/after bariatric
surgery?
In order to update the evidence base from the 2014 BOMSS
guidelines,5 the Cochrane library, NHS Evidence and the HDAS
database platform, specifically Medline, PubMed, Cinahl and Embase
databases, were searched from 2014 to January 2018 to identify
studies and publications related to the nutritional care of adult and/or
adolescent patients pre- or post-bariatric surgery. This included
studies on the prevention, incidence, prevalence or treatment of
nutritional deficiencies pre- and/or post-bariatric surgery. For prag-
matic reasons, the searches were restricted to publications written in
English. A sample search strategy can be found in Table S1. We also
screened any publications suggested by members of the guidelines
group based on their knowledge of their own areas of expertise.
Studies were included if they addressed the care of adults or ado-
lescents who were planning or had undergone a bariatric surgical pro-
cedure. We focused on AGB, SG, RYGB and BPD/DS as these were
the most common procedures undertaken at the time of the literature
search. To be included, papers were required to report data on the
nutritional care of people undergoing bariatric surgery. This included
both pre- and post-bariatric surgery care and both nutritional monitor-
ing and treatment to manage nutritional deficiencies. We excluded
studies in one anastomosis gastric bypass/mini gastric bypass
(OAGB/MGB) and single anastomosis duodenal ileal bypass with
sleeve gastrectomy (SADIS), because of the scarcity of long-term data
at that time and excluded studies on groups with conditions that in
themselves may lead to nutritional problems, such as coeliac disease.
We included any study type as well as previous relevant clinical
guidelines but excluded letters, editorials and conference abstracts.
Titles and abstracts were screened for inclusion (MO, HP, CH, JP,
RB, JB, JM, EA, RW, KM, MS and GP). Full papers were screened by
two independent reviewers (MO and HP). All of the author group,
except the patient representatives, were then divided into pairs of
independent reviewers, and a standardized data extraction form was
used to characterize the population, intervention, control groups
(where appropriate) and study outcomes and to appraise the quality
of the study. Disagreements were resolved by discussion or by a third
reviewer. Study quality was assessed using an established quality
assessment tool appropriate for each study type.20–27 (See Table S2
for details of the quality assessment tools).
Data extracted from the studies were initially synthesized by MO
with discussion with members of the guidelines group on specific
areas of expertise where needed. Early proposed recommendations
TABLE 1 Levels of evidence, grades of recommendations and
good practice points (SIGN 5028)
Levels of evidence
1++ High-quality meta-analyses, systematic reviews of RCTs or
RCTs with a very low risk of bias
1+ Well-conducted meta-analyses, systematic reviews or RCTs
with a low risk of bias
1- Meta-analyses, systematic reviews or RCTs with a high risk
of bias
2++ High-quality systematic reviews of case control or cohort
studies
High-quality case-control or cohort studies with a very low
risk of confounding or bias and a high probability that the
relationship is causal
2+ Well-conducted case-control or cohort studies with a low
risk of confounding or bias and a moderate probability
that the relationship is causal
2- Case-control or cohort studies with a high risk of
confounding or bias and a significant risk that the
relationship is not causal
3 Non-analytical studies, e.g., case reports and case series
4 Expert opinion
Grades of recommendation
The grade of recommendation relates to the strength of supporting
evidence and not the clinical importance of the recommendation
A At least one meta-analysis, systematic review or RCT rated
as 1++ and directly applicable to the target population; or
A body of evidence consisting principally of studies rated as
1+, directly applicable to the target population and
demonstrating overall consistency of results
B A body of evidence including studies rated as 2++, directly
applicable to the target population and demonstrating
overall consistency of results; or
Extrapolated evidence from studies rated as 1++ or 1+
C A body of evidence including studies rated as 2+, directly
applicable to the target population and demonstrating
overall consistency of results; or
D Extrapolated evidence from studies rated as 2++
Evidence level 3 or 4; or
Extrapolated evidence from studies rated as 2+
Good practice point
GPP Recommended best practice based on the clinical
experience of the guideline development group
Abbreviation: RCTs, randomized controlled trials.
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were circulated amongst the guideline group for iterative discussion
and review. Following this, the contributing evidence and recommen-
dations were graded based on Scottish Intercollegiate Guidelines Net-
work28 (SIGN) methodology (see Table 1) by two independent
reviewers (MO and HP). Draft recommendations together with their
grading were then circulated within the guideline group in an iterative
process until consensus was achieved on both the recommendations
and grading. Although we included previously published guidelines in
our literature review, we graded those recommendations as being
expert opinion unless we had reviewed the original articles cited by
the authors. Just prior to submission, “Clinical practice guidelines for
the perioperative nutrition, metabolic, and nonsurgical support
of patients undergoing bariatric procedures - 2019 update were
published so were included.”4
3 | RESULTS
The searches identified 601 studies, 510 of which were identified
through database searches and 91 from other sources. One hundred
and seventy-one full papers were screened, and 139 were included.
The main reasons papers were excluded were that no relevant
nutritional data were reported or that the study population did not
include people who had undergone bariatric surgery. The 32 full
papers removed with reasons for exclusion are listed as Supporting
Information inTable S3.
4 | SUMMARY OF THE STUDIES
Pre-bariatric surgery studies included seven cross-sectional and two
cohort studies. Pre- and post-bariatric surgery studies included one
non-randomized controlled trials (CTs), one randomized controlled
trials (RCTs), 20 cohort studies, one case control study, seven
systematic reviews, eight narrative reviews and seven clinical practice
guidelines. Post-surgery only studies included two CTs, six RCTs,
30 cohort studies, two case control studies, seven cross-sectional
studies, one case series, 10 case studies, one survey, nine systematic
reviews, seven narrative reviews and 10 clinical practice guidelines.
Eight studies/reviews included adolescents only, and one included
both adolescents and adults. The rest of the papers included adults
only. There were 45 studies or systematic reviews, which included
SG; 74 included RYGB; 29 included BPD/DS; and 17 included AGB.
Most clinical practice guidelines and narrative reviews focused on a
range of procedures including AGB, SG, RYGB and BPD/DS. Studies
were conducted in a variety of geographical areas including Australia,
Canada, Middle East, South America and Asian countries (23 studies
in total), but the majority were conducted in Europe (73 studies) or in
the United States (40 studies). Follow-up in the postoperative studies
varied between 6 months and 15 years. The majority reported at
1 year with smaller numbers reported at 5, 10 or 15 years. Forty-nine
studies reported on a range of micronutrients; 18 focused on
vitamin D, calcium or bone health; 17 focused on anaemia, iron,
folate or vitamin B12; eight focused on nutrition issues related to
neurological disorders; and seven focused on trace minerals.
5 | OVERVIEW AND RATIONALE FOR
RECOMMENDATIONS
There is a high prevalence of nutritional deficiencies in both adults
and adolescents with severe and complex obesity. The most common
deficiencies include anaemia, ferritin, folate, vitamin B12 and
vitamin D.15,29–50 Less frequently, lower levels of thiamine,36,43
vitamin A50 and zinc and copper33 have been reported. Following
surgery, the risk of nutritional deficiencies increases because of the
impact of bariatric surgery on both oral intake and absorption.
6 | PREOPERATIVE CARE
All people should have a comprehensive nutritional assessment prior
to bariatric surgery. Detailed preoperative care recommendations
are listed in Table 2. A specialist dietitian, skilled in bariatric
nutrition, should undertake a detailed dietary and nutritional
assessment.1–5,13,51 Essential preoperative blood tests include
screening for nutritional deficiencies, diabetes, dyslipidaemia and renal
function.2–4,9,10,12–14,52–54 Additional discretionary tests should be
considered if clinically indicated: for instance, vitamin A, zinc, copper
and selenium serum levels before malabsorptive procedures such as
BPD/DS,3,4 because of the higher levels of postoperative deficiencies.
(See Sections 7.4 and 7.5).
Nutritional deficiencies should be investigated and corrected
as clinically indicated before surgery.3 The dietitian should continue
to give support and education as part of preoperative
preparation.3,14,51,54
Many centres recommend that people follow a low calorie/low
carbohydrate diet immediately prior to surgery to reduce the size of
the liver.55 As these diets are not always nutritionally complete, a
multivitamin and mineral supplement are needed.56
6.1 | Haematinics
Prevalences of iron deficiency and low haemoglobin levels ranging
from 0% to 47% have been reported in people going forward for
bariatric surgery.15,30–33,35–37,41,43,46,49,57–59 Reports of folate
deficiency before bariatric surgery have ranged between 0% and
63%,15,30,34,36,50,60 and between 0% to 23% for vitamin B12
deficiency.29,30,32-34,36,40,41.43,47,50,58
6.2 | Vitamin D, calcium and parathyroid hormone
Vitamin D deficiency is common in people with severe and complex
obesity19,29,30,32,34,38,40,42–48,50,58,61–65 with reports as high as 99% of
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participants in one study conducted by Ben-Porat et al.40 A raised
albumin-adjusted serum calcium in the presence of raised parathyroid
hormone (PTH) may indicate primary hyperparathyroidism, and so
both PTH and calcium should be measured preoperatively.66 If
primary hyperparathyroidism is suspected, advice should be sought
from a specialist in this area.66
6.3 | Vitamin A, zinc, copper, selenium and
malabsorptive procedures
The reported prevalence of vitamin A deficiency where tested is
low.29,38,39,43,50 Zinc, copper and selenium deficiencies are not com-
monly reported prior to surgery,30,36,37,67 although De Luis et al.33
reported prevalences of 73.9% and 63.8% deficiency, respectively, for
zinc and copper. We did not consider that there was strong evidence
for routine checking of vitamin A, zinc, copper and selenium levels
prior to bariatric surgery unless there is suspicion of deficiency.
Malabsorptive procedures such as BPD/DS are associated with
an increased incidence of vitamin A, zinc, copper and selenium
deficiencies,68–74 and so consideration may be given to checking
these preoperatively before these procedures.
6.4 | Thiamine
Few studies measure thiamine levels preoperatively. However, low
levels have been reported in some people.36,43 We did not consider
there was strong evidence for routine checking of thiamine levels.
6.5 | Magnesium
Few studies have measured magnesium prior to surgery.36,58 Low
prevalence of magnesium deficiency is reported.36,58
6.6 | HbA1c, lipids, liver and renal function
These guidelines do not specifically address the preoperative medical
assessment of people with type 2 diabetes. However, biochemical
monitoring is an important part of preoperative and postoperative
care, because bariatric surgery is used to manage type 2 diabetes and
its associated comorbidities.1,10,75,76 Therefore, a brief summary of
these important aspects of care is included here.
6.6.1 | Preoperative and perioperative management
of diabetes
People with known type 2 diabetes should have an up-to-date
preoperative evaluation of current glycaemic control including
measurement of HbA1c, and glycaemic control should be optimized
TABLE 2 Preoperative nutritional assessment
Preoperative nutritional assessment
Grade, evidence level,
(range of evidence)
Recommendations
•All people should have a
comprehensive nutritional assessment
prior to bariatric surgery
Grade D EL 4
Haematinics
•Check full blood count including
haemoglobin, ferritin, folate and
vitamin B12 levels
Grade B EL 2 (1+ to 4)
Vitamin D, calcium and parathyroid hormone
•Check serum 25-hydroxyvitamin D
levels
Grade B EL 2 (2++ to 3)
•Check serum calcium levels Grade D EL 4
•Check serum/plasma parathyroid
hormone levels
Grade B EL 2 (2++ to 3)
•Seek advice from a specialist with
expertise in primary
hyperparathyroidism if primary
hyperparathyroidism is suspected
GPP
Vitamin A, zinc, copper, selenium and malabsorptive procedures
•Consider checking serum vitamin A
levels in individuals going forward
for malabsorptive procedures such
as BPD/DS or where vitamin A
deficiency may be suspected
GPP
•Consider checking serum zinc, copper
and selenium levels in individuals
going forward for malabsorptive
procedures such as BPD/DS or if a
deficiency is suspected
GPP
Thiamine
•There is insufficient evidence to
support a recommendation to
screen an individual's thiamine levels
pre surgery; however, some
individuals may have low levels
Grade D EL 3 (2− to 3)
Magnesium
•There is insufficient evidence to
support a recommendation to
screen an individual's magnesium
level pre-surgery
GPP
HbA1c, lipids, liver and renal function
•Routinely screen HbA1c, lipid profile,
liver and kidney function tests and
treat as necessary
GPP
Correction of nutritional deficiencies preoperatively
•Treat and correct nutritional
deficiencies preoperatively as
individuals have an increased risk of
deficiencies postoperatively
GPP
Abbreviations: BPD/DS, duodenal switch; EL, evidence level and depicts
where the majority of evidence lies; GPP, good practice point. The range
of evidence level is given in brackets.
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before surgery.10 Insulin and other diabetes medications should be
reviewed and adjusted as appropriate.10 The European Association
for the Study of Obesity taskforce has made detailed suggestions for
perioperative management of diabetes.10 The preoperative HbA1c is
also a baseline from which the impact of bariatric surgery and
subsequent medication adjustments are assessed. This assessment is
essential in planning postoperative diabetes management, especially if
withdrawal of insulin is planned.10
Preoperative consideration of diabetes aetiology is important if
this is not already known, because the expected impact of bariatric
surgery on glycaemic control differs between type 1 and type 2
diabetes. People with type 1 diabetes have absolute insulin deficiency,
and while people with obesity and type 1 diabetes may achieve
improved glycaemic control following bariatric surgery,77 they will
not be expected to achieve glycaemic remission and insulin with-
drawal. Furthermore, in one single-centre observational study, the
postoperative occurrence of both diabetic ketoacidosis and
hypoglycaemia was observed in people with type 1 diabetes
undergoing bariatric surgery.78 Therefore, people with type
1 diabetes require careful blood glucose monitoring to detect
reducing insulin requirements.
The presence and extent of diabetes complications should also be
noted preoperatively because long-term monitoring of existing
microvascular complications may still be required. There is also some
evidence in one small case series that the abrupt glycaemic
improvement following bariatric surgery can exacerbate proliferative
diabetic retinopathy.79
Finally, people without known diabetes should routinely undergo
preoperative screening for diabetes. Appropriate tests include
HbA1c and fasting plasma glucose (FPG) and/or a discretionary oral
glucose tolerance test. Diabetes should be diagnosed according to
established criteria.80
6.6.2 | Dyslipidaemia, liver and renal function
People with pre-existing treated dyslipidaemia should undergo a
preoperative fasting lipid profile, as a baseline from which to assess
the subsequent effect of bariatric surgery on dyslipidaemia during
follow-up.4,81
The most common liver abnormality in this patient group is non-
alcoholi fatty liver disease (NAFLD) and bariatric surgery results in
pronounced improvements.82 Therefore, it is appropriate routinely to
check liver function preoperatively to assess for the presence of
NAFLD and as a baseline for any long-term monitoring.
6.7 | Correction of nutritional deficiencies
preoperatively
As bariatric surgery impacts on oral intake and absorption, we
recommend treatment and correction of deficiencies preoperatively.3
See Section 9.
7 | POSTOPERATIVE CARE AND
BIOCHEMICAL MONITORING
People should have access to lifelong monitoring following bariatric
surgery to ensure that nutritional requirements are met, and risks of
developing post-bariatric surgery–related nutritional deficiencies are
reduced.1–4,8,10,12–14,83 The type and frequency of nutritional
monitoring should reflect the bariatric procedure and may need to be
individualized. The follow-up care should remain with the bariatric
surgery centre for the first 2 years.1,8,83 Following discharge, people
should be offered lifelong monitoring of nutritional status at least
annually as part of shared-care management.1,8,83 Detailed
recommendations are listed inTable 3.
7.1 | Urea and electrolytes, renal and liver function
tests
Renal function should be monitored for all procedures. Initially follow-
ing surgery, people may have difficulty in maintaining an adequate
fluid intake and become dehydrated.51 Routine postoperative
monitoring of liver function is also appropriate,2,84 to document
changes in NAFLD, as well as part of general safety monitoring
for hypoalbuminaemia, which may indicate underlying infection
and inflammation.
7.2 | Haematinics
There is a high incidence of iron deficiency anaemia following bariatric
surgery because of low dietary iron intake, reduced intestinal absorption
and, for some women, menstruation.15,18,19,35–37,41,57–60,72–74,85–94
Vitamin B12 absorption is adversely affected by SG, RYGB
and BPD/DS as it requires an acidic environment and presence
of intrinsic factor produced by the gastric parietal cells.95
Many people have about 2-year stores of vitamin B12; there-
fore, deficiency may present several years after
surgery.15,18,19,40,41,47,57–59,65,73,86–89,92,93,96 Vitamin B12 defi-
ciency impacts adversely on the haematopoietic and nervous
systems and may result in megaloblastic anaemia and irrevers-
ible neuropathies.95 Vitamin B12 levels are not a good predic-
tor of deficiency because methodological problems affect
sensitivity and specificity.97 In view of this, methylmalonic acid
(MMA) has been proposed as a better indicator, but this
requires a sensitive plasma assay not routinely available in the
United Kingdom.98,99 If there is doubt about vitamin B12 defi-
ciency, it is better to treat.97
Because folic acid is absorbed in the small bowel,95 absorption may
be affected by RYGB or BPD/DS, but deficiency is also observed follow-
ing SG so is more likely to be due to low dietary intake or non-adherence
with vitamin and mineral supplementation.15,18,19,32,34,40,41,47,87,100,101
It should be noted that megaloblastic and macrocytic anaemia,
associated with vitamin B12 deficiency, can be masked by folic acid
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TABLE 3 Postoperative care and biochemical monitoring
Postoperative care and biochemical monitoring
Grade, evidence level, range
of evidence
Recommendations
•Specialist postoperative dietetic support should be provided including individualized nutritional supplementation,
support and guidance to achieve long-term weight loss and weight maintenance
Grade D EL 4
•People who have bariatric surgery should have a postoperative follow-up care package within the bariatric
surgery service for a minimum of 2 years. This should include monitoring nutritional intake, dietary and
nutritional assessment, advice and support
Grade D EL 4
•People discharged from bariatric surgery service follow-up should undergo monitoring of nutritional status at
least once a year as part of a shared care model of management
Grade D EL 4
Urea and electrolytes, renal and liver function tests
•Monitor renal and liver function 3, 6 and 12 months in the first year and then at least annually GPP
Haematinics
Full blood count and ferritin
•Check full blood count and serum ferritin at regular intervals post-surgery Grade B EL 2 (2+ to 2−)
•Consider the following frequency of monitoring of full blood count and ferritin levels: 3, 6 and 12 months in the
first year and at least annually thereafter so that changes in status may be detected
GPP
Folate
•Check serum folate levels at regular intervals post-surgery Grade B EL 2 (1+ to 2−)
•Consider the following frequency of monitoring of serum folate levels: 3, 6 and 12 months in the first year and
at least annually thereafter so that changes in status may be detected
GPP
Vitamin B12
•Check vitamin B12 levels at regular intervals following SG, RYGB and malabsorptive procedures such as BPD/DS Grade B EL 2 (2++ to 2−)
•Consider the following frequency of monitoring of vitamin B12 levels: 3, 6 and 12 months in the first year and at
least annually thereafter so that changes in status may be detected
GPP
Vitamin D, calcium and parathyroid hormone
Vitamin D
•Check serum 25-hydroxyvitamin D levels at regular intervals post-surgery Grade B EL 2 (1+ to 3)
•Serum 25-hydroxyvitamin D levels of 75 nmol/L or greater are considered sufficient. Grade D EL 4
•Ensure total 25-hydroxyvitamin D (D3 and D2) is measured if patient is on vitamin D2 supplements, e.g.,
ergocalciferol
GPP
•Consider the following frequency of monitoring of vitamin D levels: 3, 6 and 12 months in the first year and at
least annually thereafter so that changes in status may be detected
GPP
Calcium
•Check serum calcium levels at regular intervals GPP
•Consider the following frequency of monitoring of serum calcium levels: 3, 6 and 12 months in the first year and
at least annually thereafter so that changes in status may be detected
GPP
Parathyroid hormone
•Check parathyroid hormone (to exclude primary hyperparathyroidism) if it has not been checked prior to surgery GPP
Fat-soluble vitamins A, E and K
Vitamin A
• Consider checking serum vitamin A levels if patient reports steatorrhoea or symptoms of vitamin A deficiency,
for example, night blindness or protein malnutrition
Grade D EL 4 (2+ to 4)
•Check serum vitamin A levels at regular intervals following malabsorptive procedures such as BPD/DS Grade B EL 2 (1+ to 2)
•Consider the following frequency of monitoring of serum vitamin A levels following malabsorptive procedures
such as BPD/DS: every 3 months and then annually once levels are stable
GPP
Vitamin E
•Check serum vitamin E levels at regular intervals following malabsorptive procedures such as BPD/DS Grade B EL 2 (1+ to 2+)
•Consider monitoring of serum vitamin E levels at least annually following malabsorptive procedures such as
BPD/DS
GPP
•Check serum vitamin E levels if unexplained anaemia or neuropathy Grade D EL 4
(Continues)
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supplementation, high folate levels or iron deficiency.95 It is essential
to assess all haematinics before recommending additional folic acid
supplements.97,102
7.3 | Vitamin D, calcium and PTH
Vitamin D plays an important part in musculoskeletal health and is
essential for calcium absorption and bone mineralization.44,48,64,103,104
Following bariatric surgery, the desirable serum 25-hydroxyvitamin D
(25OHD) levels to optimize bone health, prevent secondary hyper-
parathyroidism, improve bone mineral density and calcium balance,
and decrease fracture risk, are not known.44,48 Many guidelines rec-
ommend 25OHD levels of >75 nmol L−1.2–4,52 However, Chaktoura
suggested that these were based on expert opinion rather than robust
evidence and proposed serum 25OHD levels of 50 nmol L−1 with a
call for further research.48
Normal 25OHD levels accompanied by persistently elevated PTH
and high serum calcium levels may be an indication of primary
hyperparathyroidism hence the need to check PTH levels at
baseline.10 All people are at risk of developing vitamin D deficiency
following bariatric surgery,44 but those who have more malabsorptive
procedures are at greater risk.68–73,89,94 Therefore, serum calcium and
25OHD levels should be monitored following bariatric surgery. If
vitamin D supplementation is adjusted, serum calcium and 25OHD
levels should be rechecked.105
7.4 | Fat-soluble vitamins A, E and K
Vitamin A deficiency has been reported after RYGB and in
adolescents.15,93,106–108 Although clinical problems rarely occur,
consideration should be given to monitoring serum vitamin A levels if
there are concerns such as deterioration in night vision, dry eyes or
protein–energy malnutrition.3,4,53 Vitamin A deficiency is more
common following BPD/DS.68–74 Consequently, after malabsorptive
procedures such as BPD/DS procedures, there should be routine
monitoring of serum vitamin A levels. Many primary and secondary
TABLE 3 (Continued)
Postoperative care and biochemical monitoring
Grade, evidence level, range
of evidence
Vitamin K
•Check vitamin K1 and PIVKA-II levels at regular intervals following malabsorptive procedures such as BPD/DS Grade B EL 2 (1+ to 3)
•Consider monitoring of serum vitamin K1 and PIVKA levels at least annually following malabsorptive procedures
such as BPD/DS
GPP
Trace minerals: zinc, copper, selenium and magnesium
Zinc
•Check serum/plasma zinc levels at regular intervals following SG, RYGB or BPD/DS Grade B EL 2 (1+ to 3)
•Consider monitoring serum/plasma zinc levels at least annually following SG, RYGB or BPD/DS GPP
•Check serum/plasma zinc levels if unexplained anaemia, hair loss or changes in taste acuity GPP
Copper
•Check serum copper levels at regular intervals following SG, RYGB or BPD/DS Grade C EL 3 (2− to 3)
•Consider monitoring serum copper levels at least annually following SG, RYGB or BPD/DS GPP
• serum copper levels if unexplained anaemia or poor wound healing GPP
•Serum copper should be monitored in patients taking zinc supplements and vice versa GPP
Selenium
•Check serum selenium levels if there is chronic diarrhoea, metabolic bone disease, unexplained anaemia or
unexplained cardiomyopathy
Grade D EL 4
•Check serum selenium levels at regular intervals following RYGB
•Check serum selenium levels at regular intervals following malabsorptive procedures such as BPD/DS
•Consider monitoring serum selenium levels at least annually following RYGB or malabsorptive procedures such
as BPD/DS
Grade D EL 2 (2−)
Grade C EL 2 (2+)
GPP
Thiamine
•If the patient presents with rapid weight loss, poor dietary intake, vomiting, alcohol abuse, oedema or symptoms
of neuropathy, initiate treatment for thiamine deficiency immediately. Do not delay pending blood results
GPP
HbA1c, lipids
•Monitor HbA1c in patients with preoperative diabetes GPP
•Monitor lipids in patients with preoperative dyslipidaemia GPP
Abbreviations: AGB, adjustable gastric band; BPD/DS, duodenal switch; EL, evidence level and depicts where the majority of evidence lies; GPP, good
practice point; PIVKA-II, protein induced by vitamin K absence or antagonism; RYGB, Roux-en-Y gastric bypass, SG, sleeve gastrectomy.
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care providers are unable to request vitamin A monitoring, and
interpretation of levels should be treated with caution as they do not
directly reflect the body's vitamin A pool.109
Vitamins E and K deficiencies have been reported following
BPD/DS,69,70,72,73,94 but we found no reports after AGB, SG32 or
RYGB.93 Vitamin E is normally assessed by serum α-tocopherol, which
is transported non-specifically in lipoproteins. When considering
vitamin E nutritional status, adjustment should therefore be made for
serum lipid levels.110 Vitamin K levels should be monitored by
measuring serum vitamin K1 and protein induced by vitamin K
absence or antagonism (PIVKA-II).111 This creates a dilemma as many
centres are unable to request measurement of vitamin K, and
coagulation screens are not a reliable indication of vitamin K status.111
Consequently, we recommend that postoperative care of people
following malabsorptive procedures (BPD/DS) should remain with
specialist centres lifelong with routine monitoring of serum vitamin E
and K levels.
Following AGB, SG or RYGB, routine monitoring of serum vitamin
E and K levels is not recommended but may be measured in people
presenting with unexplained anaemia, neuropathy, bruising or
uncontrolled bleeding.2–4,51
7.5 | Trace minerals: zinc, copper, selenium and
magnesium
Zinc deficiency occasionally occurs following SG or RYGB and more
commonly following BPD/DS.31,36,37,53,58,67,69,72–74,89,94,101,112,113
Factors may include length of time after surgery and limb
length.112,113 Zinc deficiency may present as poor wound healing,
taste changes, glossitis and hair loss.53 Serum/plasma zinc levels
should be monitored if there are unexplained symptoms including
anaemia or changes in taste acuity and at least annually following SG,
RYGB and BPD/DS.2–4
Copper deficiency may present following RYGB37,67,114–117 and
more commonly following BPD/DS.72,89,112 Symptoms include
anaemia, leucopoenia, thrombocytopenia and neuromuscular
abnormalities.114,115,118–120 Elhag et al.19 reported a fall in copper
levels in adolescents who had SG. In addition, high-dose zinc
supplementation over time can cause copper deficiency and vice
versa.118–120 Serum copper should be monitored following SG, RYGB
and BPD/DS, in people who are on high doses of zinc and in people
who present with unexplained anaemia and myeloneuropathy.2–4
Serum selenium levels are not commonly measured, but defi-
ciency has been reported after SG, RYGB and BPD/DS.67,69,73,89,107
Given that there are reports of selenium deficiency, we recommend
routine monitoring of serum selenium levels after SG, RYGB and
BPD/DS or if there is chronic diarrhoea, metabolic bone disease,
unexplained anaemia or unexplained cardiomyopathy.2,4
There was insufficient evidence to recommend routine
monitoring of magnesium; however, people with hypocalcaemia
should be investigated for hypomagnesaemia and treated prior to
calcium supplementation.121
7.6 | Thiamine
People are at risk of developing thiamine deficiency if they experience
prolonged vomiting, rapid weight loss, poor dietary intake, alcohol
abuse, oedema or symptoms of neuropathy.34,122–128 All healthcare
professionals involved in the aftercare of bariatric surgery patients
should be aware of the potential risk for severe thiamine deficiency
(see Sections 8.9 and 9.6).
Symptoms of thiamine deficiency include ataxia, confusion and
coma (Cerebral Beri Beri and Wernicke's encephalopathy), neuropathy
and neuritis especially in lower limbs (Dry Beri Beri) or cardiac
insufficiency with tachycardia and respiratory symptom (Wet Beri
Beri).95,124,125 If thiamine deficiency is suspected, either because of
risk factors or clinical symptoms, oral or intravenous treatment should
be initiated immediately and not delayed pending tests results.
7.7 | Dyslipidaemia
Treatment needs for dyslipidaemia should be reassessed after
achievement of weight loss.10
8 | VITAMIN AND MINERAL
SUPPLEMENTATION
Because peoples' requirements and adherence may vary over time,
we recommend that supplements should be reviewed regularly and
adjusted accordingly. Details of the recommended vitamin and mineral
supplements are shown inTable 4.
8.1 | Complete multivitamin and mineral
supplements
Following all bariatric procedures, a complete multivitamin and
mineral supplement (containing thiamine, iron, zinc, copper and
selenium) is recommended.2–4 A minimum of 2 mg of copper and
15-mg zinc per day is advised following SG, RYGB and BPD/DS (see
Section 8.7). Care should be taken to check that the multivitamin and
mineral supplement contains sufficient amounts of vitamins and
minerals to counter the malabsorptive effects of bariatric surgery;
however, additional supplements will be needed.
8.2 | Iron
Following insertion of AGB, people should be able to meet their iron
requirements by oral diet and a complete multivitamin and mineral sup-
plement containing the recommended daily allowance of iron. A dietetic
review may be needed to check nutritional adequacy of their diet.129
Following SG, RYGB and malabsorptive procedures such as
BPD/DS, a complete multivitamin and mineral supplement may not
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TABLE 4 Postoperative vitamin and mineral supplementation
Postoperative vitamin and mineral supplementation
Grade, evidence level (EL), (range
of evidence)
Recommendations
•Vitamin and mineral supplements should be reviewed regularly and adjusted accordingly GPP
•A complete multivitamin and mineral supplement (containing thiamine, iron, selenium, zinc and copper) is
recommended daily after all bariatric procedures
GPP
Iron
•Following AGB, consider recommending a multivitamin and mineral supplement containing iron to people,
especially adolescents, as oral dietary intake of iron may be low
GPP
•Following SG, RYGB or malabsorptive procedures such as BPD/DS, recommend that people take additional
elemental iron
Grade B EL 2 (1+ to 2−)
•Consider starting with 200-mg ferrous sulphate, 210-mg ferrous fumarate or 300-mg ferrous gluconate daily
and twice daily in menstruating women and adjust depending on blood results
Grade B EL 2 (1+ to 2−)
•Consider advising people to take iron supplements with citrus fruits/drinks or vitamin C GPP
•Consider advising people to take calcium and iron 2 h apart as one may inhibit absorption of the other GPP
Folic acid
•Advise people to take a complete multivitamin and mineral supplement providing 400- to 800-μg folic acid
per day
Grade D EL 4 (1+ to 4)
Vitamin B12
•Following SG, RYGB or malabsorptive procedures such as BPD/DS, recommend routine supplementation
with vitamin B12 intramuscular injections
Grade B level 2 (1+ to 2−)
•Following SG, RYGB or malabsorptive procedures such as BPD/DS, recommended frequency of vitamin B12
intramuscular injections is every 3 months
GPP
Calcium and vitamin D
Vitamin D
•Adjust vitamin D3 supplementation to maintain serum 25-hydroxyvitamin D levels of 75 nmol L−1 or higher Grade D EL 4 (2 to 4)
•Maintenance levels of between 2000 and 4000 IU oral vitamin D3 per day may be required following SG
and RYGB and higher following malabsorptive procedures such as BPD/DS
Grade D EL 4 (2 to 4)
Calcium
•Ensure good dietary calcium intake, recognizing that requirements may be higher in individuals who have
SG, RYGB or malabsorptive procedures such as BPD/DS. If PTH is raised, despite adequate serum
25-hydroxyvitamin D levels and calcium is normal then consider a combined vitamin D and calcium
supplement
GPP
•To aid calcium absorption, advise that calcium taken as equally divided doses; calcium carbonate with food;
calcium citrate with or without food
GPP
•Calcium citrate may be the preferred supplement for people at risk of developing kidney stones GPP
Vitamins A, E and K
Vitamin A
•Following bariatric surgery, recommend that individuals take a complete multivitamin and mineral
supplement containing U.K. government dietary recommendations for vitamin A
GPP
•Following RYGB, especially in people, consider that some may require additional routine oral vitamin A
supplementation, especially if symptoms such as deterioration in night vision and dry eyes are present
Grade C EL 2 (1− to 4)
•Following malabsorptive procedures such as BPD/DS, recommend daily supplementation with additional
oral vitamin A
Grade B EL 2 (1+ to 3)
•Following malabsorptive procedures such as BPD/DS, we suggest starting at 10 000 IU (3000 μg) oral
vitamin A daily and adjust as necessary
GPP
Vitamin E
•Following malabsorptive procedures such BPD/DS, recommend daily oral supplementation with additional
vitamin E
Grade C EL 2 (1+ to 4)
•Following malabsorptive procedures such BPD/DS, we suggest starting with 100-IU oral vitamin E daily and
adjust as necessary
GPP
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prevent iron deficiency, and additional elemental iron is
required.2–4,19,34,35,74,92,130 We suggest adding 200-mg ferrous
sulphate, 210-mg ferrous fumarate or 300-mg ferrous gluconate daily.
However, this may not be sufficient to prevent anaemia.35,47,74,88,89
Women, of reproductive age and who are menstruating, have
additional requirements of 50- to 100-mg elemental iron daily
(i.e., two 200-mg ferrous sulphate or 210-mg ferrous fumarate tablets
daily).53,130 Taking iron supplements alongside citrus fruits/drinks or
vitamin C may aid absorption. Iron and calcium supplements should
be taken 1–2 h apart to avoid affecting absorption of each.3,53
8.3 | Folic acid
Folic acid requirements for people who have undergone bariatric
surgery are unknown. Complete multivitamin and minerals that con-
tain less than 400 μg daily may not be sufficient to prevent
deficiencies.3 There are increased requirements for preconceptual
care, pregnancy and lactation (see Section 9.8).11,131
8.4 | Vitamin B12
Given the risk of developing vitamin B12 deficiency following SG,
RYGB and BPD/DS (see Section 7.2), additional vitamin B12
supplementation is required for prevention. Untreated vitamin B12
deficiency may result in irreversible neuropathy or subacute combined
degeneration of spinal cord, which may occur in the absence of
megaloblastic anaemia.95,132
Discussion continues as to the optimal dosage and route of
supplementation.133–135 Some studies suggest that supplementation
with high doses of oral vitamin B12 may prevent or reduce the
development of deficiency.34,135 Further research is needed, as defi-
ciency may still occur in the presence of high oral doses.34,92,136
TABLE 4 (Continued)
Postoperative vitamin and mineral supplementation
Grade, evidence level (EL), (range
of evidence)
Vitamin K
•Following malabsorptive procedures such BPD/DS, recommend daily oral supplementation with additional
vitamin K
Grade C EL 2 (1+ to 4)
•Following malabsorptive procedures such BPD/DS, we suggest starting with 300-μg oral vitamin K daily GPP
Water-miscible forms of fat-soluble vitamins
•Water-miscible forms of fat-soluble vitamins may improve absorption especially after malabsorptive
procedures
Grade D EL 4
Zinc and copper
•Recommend a multivitamin and mineral containing at least the government recommended daily allowance
for zinc
Grade B EL 2
•Following RYGB and SG, the optimal level of zinc supplementation is not known; however, we recommend
15-mg zinc oral daily, which may be contained within the multivitamin and mineral supplement
GPP
•Following malabsorptive procedures such BPD/DS, the optimal level of zinc supplementation is not known
but will be higher than that for RYGB or SG. We recommend starting with at least 30-mg oral zinc daily,
which may be contained within the oral multivitamin and mineral supplement
Grade C EL 2
•Following RYGB, SG and BPD/DS, recommend complete multivitamin and mineral oral supplement
containing 2-mg copper
Grade D EL 4
Selenium
•Recommend a complete multivitamin and mineral supplement containing selenium Grade D EL 2 (2−)
•Following malabsorptive procedures such as BPD/DS, additional routine oral supplementation with selenium
may be needed to prevent deficiency
Grade B EL 2 (1+ to 2−)
Thiamine
•Recommend a complete multivitamin and mineral supplement containing at least government dietary
recommendations for thiamine
Grade B EL 2
•Consider recommending oral thiamine or vitamin B co strong tablets for first 3- to 4-month post-surgery GPP
•Prescribe oral thiamine 200–300 mg daily, vitamin B co strong 1 or 2 tablets, three times a day to people
with symptoms such as dysphagia, vomiting, poor dietary intake or fast weight loss
Grade D EL 4
•Clinicians should be educated about the factors, which may predispose to thiamine deficiency and the
importance of initiating immediate treatment
GPP
•People should be educated about the risks of potential thiamine deficiency and asked to seek early advice if
they experience prolonged vomiting or poor dietary intake
GPP
Abbreviations: AGB, adjustable gastric band; BPD/DS, duodenal switch; EL, evidence level and depicts where the majority of evidence lies; GPP, good
practice point; RYGB, Roux-en-Y gastric bypass; SG, sleeve gastrectomy.
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Adherence to oral supplementation is more difficult to
determine.34,96,133–135 Given the serious consequences of vitamin
B12 deficiency, we recommend routine supplementation with three
monthly intramuscular vitamin B12 injections for SG, RYGB and
malabsorptive procedures such as BPD/DS.134
8.5 | Calcium and vitamin D
Vitamin D3 supplementation requirements to maintain optimal serum
25OHD levels greater than 75 nmol L−1 post-bariatric surgery are
higher than for a non-bariatric surgery population.3,4,10,44,48,52,62,137
Starting regimens of 2000–4000 IU of vitamin D3 per day are
recommended to maintain serum 25OHD levels after surgery with
adjustments being made dependent on results.3,48,62 With
malabsorptive procedures such as BPD/DS, higher doses of vitamin
D3 supplementation are likely to be needed.52,69,70,74 Dietary intake
of vitamin D and weight bearing activity should also be encouraged.51
Calcium absorption is adversely affected by bariatric
surgery.70,138 Several guidelines recommend additional calcium
supplementation.2–4,9,51 However, the optimal calcium intake for
people who have had bariatric surgery is not known. Dietary sources
of calcium should be encouraged as it is more bioavailable than
supplemental calcium and may have a protective role in the formation
of kidney stones.139 Parrott et al. recommend 1200- to 1500-mg
calcium per day from food and supplements following AGB, SG and
RYGB and 1800–2400 mg d−1 following BPD/DS.3
Discussion continues as to whether calcium citrate should be
favoured over calcium carbonate. However, there have been no
large RCTs comparing the two supplements for all bariatric
procedures.51,103,140 Although calcium citrate may be more
bioavailable and the preferred option for people at risk of kidney
stones,141 calcium carbonate may be better tolerated.3 Parrott et al.
advise taking calcium in divided doses, taking calcium carbonate with
meals and calcium citrate with or without meals.3 Care should be
taken to ensure that there is not excess calcium intake, and healthcare
professionals should be mindful of the risk of kidney stones. Good
hydration should be encouraged.48
8.6 | Vitamins A, E and K
Following AGB and SG, people should be able to meet
requirements for vitamins A, E and K through their oral diet and a
complete multivitamin and mineral supplement. Given that lower
levels of vitamin A or deficiency has been reported after
RYGB,93,107,108 some people may require additional vitamin A
supplementation. Whilst we did not find sufficient evidence to
recommend routine additional supplementation beyond the com-
plete multivitamin and mineral supplement, this may be identified
through monitoring (see Section 7.4).
The optimum level of supplementation to prevent vitamin A
deficiency following BPD/DS is not known. There are reports of
vitamin A deficiencies developing despite supplementation of
5000–25 000 IU d−1.71,89,94 For BPD/DS with 100-cm common
channel, Homan et al.74 recommended starting vitamin A supplemen-
tation with 50 000 IU week−1, checking blood levels after 3 months
and adjusting the dosage if necessary. Homan et al.74 also estimated
that an oral dose of 7500–15 000 IU d−1 (solubilized vitamin A) is
needed to prevent vitamin A deficiency after BPD/DS, while Topart
et al.89 suggested that vitamin A 50 000 IU d−1 in tablet form was
needed to prevent deficiency. Homan et al. noted that this
difference may be due to differences in formulation, as solubilized
forms may be better absorbed.74 We recommend starting with
10 000 IU d−1 vitamin A and adjusting depending on blood results to
avoid over-supplementation.51
For prevention of vitamin E deficiency has been found post
BPD/DS, Slater et al. supplemented with 60 IU vitamin E per day
although a small number of participants still presented with vitamin E
deficiency at 4 years.70 We suggest starting with 100 IU vitamin E per
day following BPD/DS and adjusting as required.
The optimal level of vitamin K supplementation to prevent defi-
ciencies after malabsorptive procedures is not known. Although, Aills
et al. suggest 300-μg vitamin K daily.51
Water-miscible forms of fat-soluble vitamins may improve
absorption especially after malabsorptive procedures.2–4,51
8.7 | Zinc and copper
The complete multivitamin and mineral supplement may not contain
sufficient zinc to prevent deficiency following SG, RYGB or BPD/DS
(see Section 7.5). Although the optimum level of zinc supplementation
is not known, we suggest starting with 15 mg d−1 zinc, which may be
contained within the multivitamin and mineral supplement. After
BPD/DS, Topart et al.89 suggested starting with 30 mg d−1 zinc, whilst
Homan et al.74 suggested 100 mg d−1 zinc is needed to prevent defi-
ciency. Given that zinc and copper have an inverse relationship for
absorption, we recommend starting with 30 mg d−1 zinc after BPD/DS.
We recommend that all people have a complete vitamin and
mineral supplement that provides 2 mg d−1 copper.67,117 People who
have had long limbed gastric bypass or BPD/DS may have additional
requirements.74,89,112
If additional zinc supplements are given, monitor both zinc and
copper levels as normally a ratio of 8–15 mg of zinc for each 1-mg
copper should be maintained to avoid zinc-induced copper
deficiency.3,4 The current complete multivitamin and mineral available
on prescription (Forceval) in the United Kingdom contains 2-mg
copper and 15-mg zinc, and doubling up on the dosage may be
sufficient in some cases to meet the additional requirements.112
8.8 | Selenium
Although the evidence is limited, a complete multivitamin and mineral
supplement, which contains selenium, should be recommended after
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bariatric surgery. Additional selenium may be needed by some people
following RYGB and especially following BPD/DS.69,73,89,107 Over-
the-counter preparations or Brazil nuts may also be used to
supplement selenium.
8.9 | Thiamine
People are at high risk of developing thiamine deficiency post-
bariatric surgery (see Section 7.6). Garg et al. reported that people
who saw a dietitian had more favourable thiamine levels at 3-month
post-surgery.126
The complete multivitamin and mineral supplement containing
thiamine may not be sufficient to prevent deficiency. Parrott et al.
recommend that all people take 12 mg d−1 thiamine and preferably
50-mg dose of thiamine once or twice a day from a vitamin B-complex
supplement.3 We were unable to find sufficient evidence to support
this; however, we recognize that further research and evidence are
needed in this important area. For people in which there is concern
that a complete multivitamin and mineral supplement containing thia-
mine is not sufficient, consideration should be given to prescribing
additional thiamine or a vitamin B-complex supplement for the first
three to four postoperative months.
If people present with prolonged vomiting, dysphagia, poor nutri-
tional intake, inability to tolerate vitamin and mineral supplements,
high alcohol intake or fast weight loss, additional thiamine supplemen-
tation should be administered immediately to prevent the develop-
ment of Wernicke's encephalopathy.122,124–128 Consideration should
be given to admission and immediate parenteral replacement with thi-
amine in people where thiamine deficiency is suspected; see Sec-
tions 7.6 and 9.6.
Given the severe consequences that arise from untreated or late
treatment of thiamine deficiency, we recommend that people are edu-
cated about potential risks of thiamine deficiency and to seek early
advice. Clinicians in both primary and secondary care need education
on the factors that may predispose to thiamine deficiency and the
importance of initiating immediate treatment.
9 | ABNORMAL TEST RESULTS AND
CLINICAL PROBLEMS
Detailed recommendations are listed inTable 5.
9.1 | Protein malnutrition/protein–energy
malnutrition/oedema
This can present several years following bariatric surgery. Causes
include poor dietary protein intake as well as malabsorption. People
who have difficulty progressing their diet because of a stricture, over-
tight band or food intolerances are at risk in addition to those with
protein malabsorption.69,71,89,94,142
Oedema is an important indicator of protein energy malnutrition
and may mask muscle wasting and weight loss. Whilst it is necessary
to exclude the many other causes of oedema, people should also be
referred back to the bariatric centre for further investigation.
9.2 | Anaemia
9.2.1 | Iron deficiency anaemia
Iron deficiency anaemia may be dietary in origin, with oral diet and
iron supplements being insufficient to meet the needs of people fol-
lowing bariatric surgery (see Section 7.2). Sources of blood loss, both
related and unrelated to bariatric surgery, should also be considered,
investigated and excluded.143
If there is a low haemoglobin and low mean cell volume (MCV),
serum ferritin levels should be measured. Levels of serum ferritin less
than 15 μg L−1 confirm iron deficiency anaemia.143 Acute and chronic
inflammatory conditions, liver disease and malignant disease may
result in increased ferritin levels independent of iron status; therefore,
people with chronic inflammation and a ferritin concentration of
50 μg L−1 or higher could still be iron deficient. If inflammation is
thought to be affecting the ferritin levels, other markers of inflamma-
tion such as C-reactive protein or measures of iron status such as total
iron binding capacity should be considered. If there is doubt about the
tests to be requested or interpretation of results, specialist advice
should be sought.143
9.2.2 | Vitamin B12 and folate
The most common causes of megaloblastic, macrocytic anaemia are
vitamin B12 and folate deficiency,132 and folate supplementation may
mask severe vitamin B12 depletion (see Section 7.2). It is essential
that vitamin B12 deficiency is treated immediately before initiating
additional folic acid (see Section 7.2).
In vitamin B12 deficiency with possible neurological involvement,
such as unexplained sensory and/or motor and gait symptoms, vita-
min B12 deficiency should be treated immediately and urgent special-
ist advice sought from a neurologist and haematologist.132
Hydroxocobalamin 1 mg intramuscularly should be administered on
alternate days until there is no further improvement, then hydro-
xocobalamin 1 mg intramuscularly administered every 2 months.132
For people with vitamin B12 deficiency and no neurological involve-
ment, hydroxocobalamin 1 mg intramuscularly should be administered
three times a week for 2 weeks, followed by maintenance treatment
with 1 mg intramuscularly every 2–3 months for life.132
Folic acid deficiency may indicate non-adherence with the daily
multivitamin and mineral supplement or malabsorption. Some medica-
tions, such as anticonvulsants, sulfasalazine and methotrexate, may
affect folic acid levels.102 For treatment of folic acid deficiency (after
excluding vitamin B12 deficiency), oral folic acid 5 mg daily should be
given for a minimum of 4 months.132
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TABLE 5 Abnormal test results, clinical problems, pregnancy and adolescents
Abnormal test results, clinical problems, pregnancy and adolescents
Recommendations
Grade, evidence level, range
of evidence
Protein malnutrition/protein energy malnutrition/oedema
•If people present with signs/symptoms of protein malnutrition/protein energy malnutrition/oedema, investigate
potential causes and refer back to bariatric centre
GPP
Anaemia
Iron deficiency anaemia
•Sources of blood loss should be considered, investigated and excluded in individuals who present with iron
deficiency anaemia
Grade D EL4
•For people over 12 years old and pregnant women diagnosed with iron deficiency anaemia, treat iron deficiency
following NICE CKS Anaemia—iron deficiency
Grade D EL 4
Vitamin B12 deficiency
•Treat vitamin B12 deficiency immediately using NICE CKS: Anaemia—B12 and folate deficiency. Do not give
folic acid first as it may mask underlying vitamin B12 deficiency and precipitate subacute combined
degeneration of the spinal cord
Grade D EL 4
•For people with neurological involvement, NICE recommend administering hydroxocobalamin 1 mg
intramuscularly on alternate days until there is no further improvement, then administer hydroxocobalamin
1 mg intramuscularly every 2 months
Grade D EL 4
•For people with no neurological involvement, NICE recommend administering hydroxocobalamin 1 mg
intramuscularly three times a week for 2 weeks
Grade D EL 4
•After treatment of vitamin B12 deficiency, provide maintenance treatment with 1 mg intramuscularly every
2–3 months lifelong
Grade D EL 4
•Seek urgent specialist advice from neurologist and haematologist, if there is possible neurological involvement,
such as unexplained sensory and/or motor and gait symptoms
GPP
Folic acid deficiency
•Check and treat for vitamin B12 deficiency, before initiating folic acid treatment to avoid precipitation of
subacute combined degeneration of the spinal cord
Grade D EL 4
•Treat folic acid deficiency using NICE CKS: Anaemia—B12 and folate deficiency. Folic acid 5 mg orally daily for
a minimum of 4 months is recommended and further investigations if there is suspicion of malabsorption
Grade D EL 4
Unexplained anaemia/fatigue
•For unexplained causes of anaemia or fatigue, investigate for other nutritional deficiencies including protein,
zinc, copper and selenium
GPP
Low vitamin D levels
•In absence of local adult guidelines for vitamin D replacement, refer to National Osteoporosis Society guidance:
Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management
Grade D EL 4
•In absence of local children and young people guidelines for vitamin D replacement, refer to National
Osteoporosis Society guidance: A Practical Clinical Guideline for Patient Management in Children and Young
People or a paediatrician
Grade D EL 4
•If the person remains vitamin D deficient despite treatment, refer to a secondary care specialist GPP
•In people with severe vitamin D deficiency, high dose vitamin D injections might be required, which should be
given following specialist consultation, in people with known history/high risk of hypercalcaemia, e.g., people
with kidney stones, sarcoidosis, renal impairment and atrial fibrillation
GPP
Vitamin A deficiency/disturbances in night vision/xerophthalmia
•In adults, treat vitamin A deficiency, with 10 000- to 25 000-IU oral vitamin A daily for 1–2 weeks for clinical
improvement. Recheck vitamin A levels at 3 months
Grade D EL 4
•For vitamin A deficiency that does not respond to treatment, refer to specialist for assessment and
consideration of intramuscular vitamin A injections
GPP
•In adolescents, with vitamin A deficiency, refer for specialist support GPP
Vitamin E and vitamin K deficiency
•Treat vitamin E deficiency with oral vitamin E 100–400 IU d−1. Recheck levels after 3 months Grade D EL 4
•For vitamin E deficiency that does not respond to treatment, refer to specialist for assessment and
consideration of intramuscular injections
GPP
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TABLE 5 (Continued)
Abnormal test results, clinical problems, pregnancy and adolescents
Recommendations
Grade, evidence level, range
of evidence
•When considering vitamin E nutritional status, adjustment should be made for serum lipids Grade D EL 4
•For vitamin K deficiency, treat with 1- to 2-mg oral vitamin K daily (Ketovite tablets, menadiol sodium
phosphate or phytomenadione). Recheck levels after 3 months. For those on anticoagulants such as warfarin
or for vitamin K deficiency that does not respond to treatment, refer to specialist for assessment
GPP
Neurological symptoms/Wernicke's encephalopathy
In patients who present with neurological symptoms:
•Treat for thiamine deficiency (see section prolonged vomiting/dysphagia/poor oral intake/risk of thiamine
deficiency)
Grade D EL 4
•Check for vitamin B12, copper and vitamin E deficiencies and treat GPP
•Refer to neurologist and haematologist GPP
Zinc and copper deficiency
•If both zinc and copper low, consider prescribing two Forceval daily for 3 months and recheck levels GPP
•Check both zinc and copper levels when considering zinc or copper replacement
•With mild zinc or copper deficiency, consider giving two Forceval daily and recheck levels after 3 months
Grade D EL 4
GPP
•With severe zinc deficiency and normal or borderline copper levels, treat with high dose zinc supplement for
3 months and recheck levels. If no improvement or copper levels fall, refer for specialist advice
GPP
•With severe copper deficiency, refer for specialist advice GPP
•When giving additional zinc and copper, maintain a ratio of 8- to 15-mg zinc to 1-mg copper. Close monitoring
is required if higher zinc or copper doses are indicated because each affects the absorption of the other. If
necessary, ask for expert advice
Grade D EL 4
Prolonged vomiting/dysphagia/poor oral intake/risk of thiamine deficiency
•If people present with prolonged vomiting or dysphagia, refer back to the bariatric centre for investigation GPP
•People, who present with prolonged vomiting or dysphagia, are at risk of thiamine deficiency. Give additional
thiamine and vitamin B co strong immediately (thiamine 200–300 mg daily, vitamin B co strong 1 or 2 tablets,
three times a day)
Grade D EL 4
•For those unable to tolerate thiamine orally or with clinical suspicion of acute deficiency intravenous thiamine
should be given
Grade D EL 4
Pregnancy
•Women are advised to avoid pregnancy for the first 12–18 months following surgery to allow weight
stabilization and a varied nutritious diet
Grade D EL 4
•Women with a BMI < 29.9 kg m2, planning for pregnancy, should take an additional 400 micrograms/day folic
acid prior to conception until the 12th week of pregnancy
Grade D EL 4
•Women with type 2 diabetes mellitus or a BMI > 30 kg m2 should take 5-mg folic acid until the 12th week of
pregnancy. Check for vitamin B12 deficiency before starting
Grade D EL 4
•Refer to specialist antenatal care Grade D EL 4
•Replace vitamin A in supplements from retinol to beta carotene form or take preconception or pregnancy
specific vitamin and mineral supplement
Grade D EL 4
•Pregnant women, following bariatric surgery, should undergo nutritional screening during each trimester. This
should include ferritin, folate, vitamin B12, calcium, vitamin D, vitamin A
Grade D EL 4
•Pregnant women, following bariatric surgery, especially those who have had long-limbed bypass or BPD/DS
procedures, may be at risk of low vitamins E and K levels. These should be monitored during pregnancy if
clinically indicated
Grade D EL 4
•A more frequent review with the specialist bariatric dietitian may be required Grade D EL 4
•Reference ranges change in pregnancy. Please refer to perinatal reference ranges when checking blood results
http://perinatology.com/Reference/Reference Ranges/Reference for Serum.htm
GPP
Adolescents
•Adolescents who have undergone bariatric surgery should be monitored for dietary adherence and nutritional
assessment on a regular basis due to changes in body composition, growth and sexual development
GPP
(Continues)
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9.2.3 | Unexplained anaemia
Unexplained anaemia or fatigue may be a symptom of other nutri-
tional deficiencies including protein, zinc, copper and selenium so
levels of these should all be checked.2–4,114,115,117,144
9.3 | Low vitamin D levels
Although low serum 25OHD levels are not a barrier to bariatric sur-
gery, vitamin D insufficiency or deficiency should be treated preopera-
tively especially where the surgical procedure is likely to result in
reductions in serum 25OHD levels.3,44,48,52 Following surgery, if peo-
ple present with vitamin D insufficiency/deficiency, adherence with
the recommended supplements should be checked. However, for
many people, despite good adherence, additional supplementation with
vitamin D and higher maintenance doses may be required.3,44,48,62,63
Vitamin D deficiency requires correction with loading doses of
vitamin D.3,48 Many healthcare professionals have access to local
guidelines/protocols for treatment of vitamin D deficiency. In the
absence of these, the Royal Osteoporosis Society (ROS) gives
recommendations for replacement.105 For adolescents, refer to ROS
paediatric guidelines.145 For those people who remain vitamin D
deficient or need a more aggressive approach, a referral to a
secondary care specialist is recommended.
9.4 | Vitamin A deficiency
Vitamin A deficiency can lead to visual problems such as
xerophthalmia and loss of night vision106,108 and reduced male fertility
and may also result in foetal abnormalities.95,146 Vitamin A levels
should be measured if there are clinical concerns, and if appropriate, a
referral to an ophthalmologist should be considered. For treatment of
vitamin A deficiency in adults, oral supplementation with vitamin A,
10 000–25 000 IU d−1 for 1–2 weeks for clinical improvement is
recommended.3,72,84 Higher doses, including intramuscular injections,
may be needed if the person is experiencing night blindness.3,4,147
The levels should be rechecked at 3 months.72 For vitamin A
deficiency that does not respond to oral supplementation, an onward
referral to a specialist is needed as intramuscular injections may
be required.
Silva et al. highlight that there are no guidelines for vitamin A
replacement in adolescents.16 We recommend seeking specialist
advice.
9.5 | Vitamin E and vitamin K deficiency
Symptoms of vitamin E deficiency include peripheral neuropathy,
muscle weakness and ataxia.84 Oral vitamin E 100–400 IU d−1 has
been recommended for maintenance of vitamin E levels recognizing
more may be needed for repletion,3,51 while Bays et al. suggested
400- to 800-IU vitamin E.53 Serum levels should be monitored and
treatment continued until serum levels reach normal range.3,53,84 For
vitamin E deficiency that does not respond to oral supplementation,
refer onto a specialist as intramuscular injections may be needed.
Large vitamin E doses can result in over-replacement and
exacerbate vitamin K deficiency and therefore affect blood
coagulation, so care should be taken.95 Furthermore, assessment of
vitamin K should be performed when there is established fat-soluble
vitamin deficiency with hepatopathy, coagulopathy or osteoporo-
sis.2,4,148 For vitamin K deficiency, Ketovite tablets contain
acetomenaphthone (vitamin K) 500 μg per tablet and may be used to
treat vitamin K deficiency although menadiol sodium phosphate or
phytomenadione may be taken orally.149 An oral dose of 1–2 mg d−1
is recommended.3 Seek further advice from a haematologist if people
are taking anticoagulants such as warfarin. Onward referral is needed
if vitamin K deficiency does not respond to treatment.
9.6 | Deficiencies associated with neurological
symptoms/Wernicke's encephalopathy
Myeloneuropathy may have a number of causes including deficiencies
of vitamin B12, thiamine, copper or vitamin E. Beri Beri and
TABLE 5 (Continued)
Abnormal test results, clinical problems, pregnancy and adolescents
Recommendations
Grade, evidence level, range
of evidence
Malabsorptive procedures
•Individuals who have malabsorptive procedures have a higher prevalence of post-surgery nutritional
deficiencies and care should remain with the specialist centre
GPP
•For OAGB/MGB with BP limb length of 150 cm or less, follow RYGB nutritional recommendations GPP
•For OAGB/MGB with BP limb length of greater than 150 cm or SADIs, follow BPD/DS nutritional
recommendations
GPP
Abbreviations: BPD/DS, duodenal switch; CKS, clinical knowledge summary; EL, evidence level and depicts where the majority of evidence lies; GPP, good
practice point; OAGB/MGB, one anastomosis gastric bypass/mini gastric bypass; RYGB, Roux-en-Y gastric bypass; SADIs, single anastomosis duodenal ileal
bypass with sleeve gastrectomy.
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Wernicke's encephalopathy are severe complications caused by
thiamine deficiency.95 All these conditions may occur after bariatric
surgery.122,124,125,127,128,150
In people at risk of thiamine deficiency or with clinical suspicion
of acute deficiency (see Sections 7.6 and 8.9), additional thiamine
and vitamin B compound strong should be given immediately, i.e., oral
thiamine 200–300 mg d−1 and vitamin B compound strong 1 or
2 tablets three times a day, or full dose daily intravenous vitamin B
preparation, if necessary for those unable to tolerate thiamine
orally.125,151,152 Oral or intravenous glucose must not be given to
people at risk of or with suspected thiamine deficiency as it can
precipitate Wernicke–Korsakoff syndrome.122,150 All healthcare
professionals, including emergency department staff, need to be
aware of this preventable complication and its management. Note
that prolonged vomiting or dysphagia is not normal and should
always be investigated. A referral back to the bariatric centre is
recommended.
Vitamin B12, copper and vitamin E levels should be assessed and
any deficiencies corrected (see Sections 9.2.2, 9.5 and 9.7). People
with neurological symptoms should be referred to a neurologist.
9.7 | Zinc and copper deficiency
For borderline low zinc or copper levels, blood tests should be
repeated at 3 months as levels may fluctuate. In these cases, levels
may respond to two capsules a day of complete multivitamin and
mineral supplement available on prescription (Forceval). Although
normally zinc/copper ratio should be maintained when giving
additional supplements, in the case of deficiency of one of these
micronutrients and a normal level of the other, high doses of either
one may be given providing the levels of both continue to be
monitored. Where there is doubt, seek specialist advice.
9.8 | Pregnancy
Women are often advised to avoid pregnancy for the first
12–18 months following bariatric surgery.2,4,11,131 The evidence base
for this recommendation is limited; however, this helps to ensure that
the woman has reached weight stability is able to eat a varied
nutritious diet and enables appropriate planning of pregnancy and
associated care.11
Preconception care should be discussed with women who plan to
become pregnant. All women, planning for pregnancy, should take
additional folic acid to reduce the risk of foetal neural tube defects.
Prior to conception and until the 12th week of pregnancy, 400 μg d−1
folic acid is recommended. However, in women with obesity or
diabetes, the recommendation is 5 mg d−1 folic acid.11,131,153,154
Vitamin B12 should be measured during the preconception period
before additional folic acid supplements are given.
A systematic review by Jans et al. concluded that the evidence
on micronutrient deficiencies in pregnant and postpartum women
after bariatric surgery and subsequent adverse neonatal outcomes
was weak and inconclusive and called for larger prospective cohort
studies to be undertaken.146 In a retrospective study of 73 preg-
nancies in a single centre, Yau et al. did not find an increase in
nutritional deficiencies in women post-bariatric surgery who had a
shorter time from surgery to conception.155 In other studies, the
incidence of vitamin A deficiency has been seen to increase over
pregnancy.146,156,157 The incidence of vitamin K deficiency has also
been found to increase with the long-limbed gastric bypass and
BPD/DS during pregnancy.158 Vitamin K deficiency may be related
to neonatal intracranial bleedings and birth defects. The frequency
of nutritional monitoring should therefore be increased during
pregnancy.11,131 Reference values for levels may change over preg-
nancy, and it is useful to check results against sources such as
those provided by perinatology.159
Women, as part of preconception care, are advised to avoid
vitamin and mineral preparations, which contain vitamin A in the
retinol form, in the first 12 weeks of pregnancy.160 However, this
may leave them at risk of developing vitamin A deficiency.146,156
Supplements containing retinol may increase the teratogenic risk
especially in the first trimester.95 There are a number of vitamin
and mineral supplements containing no vitamin A, which are
specifically aimed at preconception and pregnancy. Supplements
containing vitamin A in the beta carotene and not retinol form
may be continued in pregnancy. It is important to check this; for
example, the capsule form of the multivitamin and mineral
supplement available on prescription is appropriate, but the soluble
form is not.
Women, who become pregnant post-bariatric surgery, should
be treated as a specialist obstetric population with specific
needs.11,131 This includes access to specialist dietetic support and
close monitoring of nutrition. They should undergo nutritional
screening every trimester.11,131 This should include ferritin, folate,
vitamin B12, calcium, vitamin D and vitamin A.11 Those who have
had long limbed bypass or BPD/DS procedures may be at risk of
low vitamins A, E and K levels and so these should be monitored
if clinically indicated.146 A more frequent review with the specialist
bariatric dietitian may be required.11,131 It should be noted that for
women, who have had a gastric band, decisions around band
management should be made in clinical context as there are
RCTs to define optimum management of the gastric band inflation
during pregnancy.4,161
9.9 | Adolescents
A number of studies, whilst giving favourable outcomes in adolescents
undergoing bariatric surgery, reported both preoperative and
postoperative nutritional deficiencies.15–19,162 Adherence to
nutritional supplements and engagement with postoperative follow-
up is a challenge in all age groups; however, adolescents are a
vulnerable group and need regular monitoring and support through
growth and sexual development.12–19
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9.10 | Nutritional care of people who have had
malabsorptive procedures
Malabsorptive procedures such as BPD/DS are associated with higher
prevalence of post-surgery nutritional deficiencies including fat-
soluble vitamins and trace minerals. The management of these
including prevention and correction of deficiencies can be difficult.
Healthcare professionals, especially in primary care, may be unable to
request specific blood tests. In addition, people may not be able to
access a full range of supplements. Unlicensed products may be
needed for the correction of deficiencies. We recommend that
individuals who have malabsorptive procedures remain under the care
of specialist centres.
9.11 | Newer procedures (OAGB/MGB and SADIs)
It is recognized that there is a growing interest in OAGB/MGB and
SADIs and that, as yet, these are not covered robustly by clinical
practice guidelines. Until such data emerge, it may be hypothesized
that requirements for nutritional supplements in people undergoing
OAGB/MGB with BP limb of 150 cm would be at least that of people
undergoing RYGB, if not more, and that nutritional requirements for
people undergoing OAGB/MGB with BP limb greater than 150 cm
and SADIS would be at least that of people undergoing the traditional
BPD/DS.163–166 We therefore recommend that healthcare profes-
sionals follow RYGB nutritional recommendations for postoperative
care after OAGB/MGB with BP limb length of 150 cm and BPD/DS
recommendations for people after OAGB/MGB with BP limb length
of greater than 150 cm or SADIs.
10 | DISCUSSION
Clinical guidelines can make a vitally important contribution to patient
safety, and a number of guidelines for the nutritional care of people
undergoing bariatric surgery have been published over the last few
years.1,3,4,8–11 However, not all have been specifically related to
micronutrition, had dietetic involvement or detail on recommenda-
tions for the nutritional management of pregnancy post-surgery. No
previous nutritional guidelines for people undergoing bariatric surgery
have included either primary care or patient representatives. Previous
guidance aimed at the management of adolescents undergoing
bariatric surgery has only included general nutritional
recommendations,12–14 despite this vulnerable group being at high
risk of developing nutritional deficiencies.15–19
Here, comprehensive, up-to-date guidelines have been developed
using robust methodology that include graded recommendations for
preoperative and postoperative nutritional monitoring, vitamin and min-
eral supplementation and correction of deficiencies for people undergo-
ing bariatric surgery. Importantly, nutritional guidance for the care of
adolescents and pregnancy post-surgery has also been included, and
the guidance development group was composed of a multidisciplinary
team from primary and secondary care as well as patient
representation. Thus, ensuring that all professions involved in preparing
people for surgery and providing aftercare, as well as patient views and
needs, were properly considered. Although these guidelines are aimed
at improving practice in the U.K. setting and take account of the current
model of healthcare in the United Kingdom, they are likely to be appli-
cable to other healthcare settings. However, we have addressed issues
specifically related to the U.K. healthcare system where possible; for
example, both specialist and non-specialist care providers may not
always able to access all the suggested nutritional blood tests such as
vitamin A and vitamin K. Correction of some nutritional deficiencies,
especially fat-soluble vitamins, can be a challenge as the use of off
license medications may be required. In addition, it is of concern that in
some parts of the United Kingdom, people are not given access to pre-
scribed vitamin and mineral supplements, particularly for those under-
going malabsorptive procedures. These people will have higher
requirements, but there is no easy access to supplements containing
larger amounts of vitamins A, E and K. This is a potentially serious issue
that must be addressed. Accessibility and affordability were amongst
the factors affecting adherence to vitamin and mineral supplements
after bariatric surgery in the United Kingdom.167
The main limitations of these guidelines are related to the current
evidence base. There have been a very limited number of RCTs
undertaken in bariatric surgery and nutrition.34,68,101,130,135,168 There
is also a lack of evidence for optimal nutritional supplementation after
bariatric surgery, which is complicated by the fact that requirements
will vary according to the surgical procedure, size of gastric pouch and
length of common channel. Because of this lack of good quality
evidence and robust studies in the area, the guideline groups were
required to make a number of recommendations based on good
practice and the expert opinion of the group (good practice points).
11 | CONCLUSION
Preoperative dietetic assessment and biochemical monitoring are vital
to ensure that people are able to meet nutritional needs after
bariatric surgery and any nutritional deficiencies are identified and
corrected.3 Long-term biochemical monitoring is important for the
detection and treatment of emergent postoperative nutritional
deficiencies.1–4,8–11,83 Annual reviews enable nutritional supplements
to be reviewed and adjusted. We have systematically reviewed the
current evidence base for the nutritional care of patients undergoing
bariatric surgery and report our consensus guidelines with graded
recommendations. These guidelines have the potential to improve
clinical practice and safety for people undergoing bariatric surgery and
should be considered for adoption by healthcare organizations. They
will be updated regularly as new evidence emerges.
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